Dear cBioportal,
I am in the process over revising a manuscript, where one of the reviewers ask:
By C-bioportal, are there HR-deficient tumors with germline or acquired mutations in the ZGRF1- or RAD54B genes and perhaps in the DUF domain?
To answer the question by the reviewer, I have followed the webinars on the cBioportal website, but I am still not entirely sure how to best answer the reviewer. Is there a way to identify HR (homologous recombination)-deficient tumors in cBioportal besides looking at co-occurance of mutations in ZGRF1- or RAD54B with mutations in known HR genes such as BRCA2?
Any help or advice would be much appreciated.
Kind regards,
Michael
**************************************************************************
Michael Lisby, Prof., Ph.D.
Copenhagen Biocenter, room 4-1-07
Department of Biology
University of Copenhagen
Ole Maaløes Vej 5
DK-2200 Copenhagen N
Denmark
**************************************************************************
E-mail:
mli...@bio.ku.dkPh:
+ 45 3532 2120X: @lisby_michael
**************************************************************************